Ann L. MacDougall - 13 May 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Ann L. MacDougall
Issuer symbol
N/A
Transactions as of
13 May 2022
Net transactions value
+$32,778
Form type
4
Filing time
16 May 2022, 16:03:23 UTC
Previous filing
16 Jun 2021
Next filing
14 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $32,778 +3,000 +13% $10.93 26,179 13 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.